Psa-based intervals
Psa-based intervals has been studied in 1 paper since 2026: none in people yet; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Feb 25, 2026: “Comparing the effectiveness of prostate cancer screening protocols: European Association of Urology- and European Randomized Study of Screening for Prostate Cancer-based strategies”.
1 paper studies it1 findingUpdated
See all 1 papers on psa-based intervals
- In silico1
What did studies of psa-based intervals find?
1Studies of psa-based intervals measured one outcome, Number of PSA tests.
Number of PSA tests
downin silico1−21%
1 study
Number of PSA tests
downin silico1−21%
Psa-based intervals decrease number of PSA tests in silico (compared to ERSPC protocol) (-21%).
“Compared to the ERSPC protocol, PSA-based intervals reduced PSA tests by 21%.”
In silicocompared to ERSPC protocolmales
International journal of cancer
Latest
1 paper in 12 monthsInternational Journal of Cancer
Comparing the effectiveness of prostate cancer screening protocols: European Association of Urology- and European Randomized Study of Screening for Prostate Cancer-based strategies
Computational studyProstate cancer